Navigation Links
Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) congratulates Mario R. Capecchi today for the richly deserved honor of the 2007 Nobel Prize in Physiology or Medicine. Capecchi, who sits on FBR's Board of Governors, is currently a Distinguished Professor and Co-Chair of the Human Genetics Department at the University of Utah, School of Medicine.

"Groundbreaking research such as Dr. Capecchi's has enabled the study of diseases in a way never before thought possible," said FBR President Frankie L. Trull. "This further demonstrates the incredible power and promise of the humane use of animal models in medical research."

The Nobel Foundation recognized Capecchi and two other researchers for the discovery of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." Their studies resulted in genetically altered mouse models, innovating the way researchers work to combat such diseases as cancer, diabetes and Alzheimer's.

Capecchi's Nobel Prize-winning work involved gene targeting in mouse embryonic stem cells, allowing scientists to study the pathology of disease in a living system whose genes have been either inactivated or modified. Scientists can now target specific disease-causing genes in an effort to discover new cures or treatments that afflict both humans and animals.

Upon joining FBR's Board of Governors, Capecchi said, "I am a very strong advocate for the respect and support of animal research. My scientific life has been devoted to the use of mouse models for the understanding of the development of therapies of human disease as well as for the pathologies."

FBR's Board of Governors now includes ten Nobel Laureates. Capecchi is a recipient of numerous other awards, including the Albert Lasker Award in 2001.

FBR is the nation's foremost organization devoted to promoting public understanding, respect, and support for the humane and responsible use of animals in medical and scientific research. For more information on FBR, please visit its Web site at http://www.fbresearch.org.


'/>"/>
SOURCE Foundation for Biomedical Research
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
5. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
6. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
7. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates
10. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... -- --> --> ... Spectroscopy Market by Industry (Oil & Gas, Petrochemical, Pharmaceutical, Water ... & Mining, and Others), And Geography - Global Forecast ... expected to grow to USD 3.9 Billion by 2020, ... 2020. Browse 82 market data Tables and ...
(Date:2/10/2016)... Feb. 10, 2016  Resolve Therapeutics, LLC, a ... approaches to the treatment of lupus and Sjogrens ... multiple ascending dose study in patients with systemic ... --> --> ... ascending dose study of RSLV-132 in 32 subjects ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... , ... Husted Kicking has completed its Third Annual Husted Kicking ... 7th, 2016 according to kicking coach Michael Husted. , “This event serves as an ... in Indianapolis,” says Husted. “The NFL uses a third party organization to select players ...
(Date:2/10/2016)... ... 2016 , ... President Obama’s budget proposal yesterday enables the ... services via telehealth, estimated to generate more than $160 million in savings over ... years. Although there is more to be done, this represents an important ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... health care communications company offering education, research and medical media, has launched ... specialists working in infectious diseases. , As the all-inclusive resource for infectious ...
(Date:2/10/2016)... NASHVILLE, Tenn. (PRWEB) , ... February 10, 2016 ... ... by the American Academy of Emergency Medicine , an emergency medicine ... of practice management services . , The American Academy of Emergency Medicine, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... announces that his office is now offering a variety of comprehensive procedures for ... enhancement, eyebrow lift, facial volume restoration, lip enhancement and nasal reshaping. , ...
Breaking Medicine News(10 mins):